Wealth Management Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
3,099
+2,500
+417% +$856K 0.31% 61
2026
Q1
$211K Buy
+599
New +$214K 0.07% 225
2025
Q3
Sell
-848
Closed -$237K 232
2025
Q2
$237K Buy
848
+1
+0.1% +$283 0.09% 191
2025
Q1
$264K Hold
847
0.11% 173
2024
Q4
$221K Buy
847
+150
+22% +$44.5K 0.09% 188
2024
Q3
$225K Hold
697
0.1% 187
2024
Q2
$218K Hold
697
0.1% 183
2024
Q1
$218K Hold
697
0.1% 183
2023
Q4
$201K Buy
+697
New +$190K 0.11% 189
2022
Q1
Sell
-2,672
Closed -$601K 189
2021
Q4
$601K Buy
+2,672
New +$564K 0.32% 82
2020
Q1
Sell
-910
Closed -$219K 124
2019
Q4
$219K Buy
+910
New +$201K 0.16% 140

Other funds holding AMGN

Wealth Management Associates's AMGN Position: Q2 2026 in Review

Wealth Management Associates increased its Amgen (AMGN) stake by 417% in Q2 2026, buying an estimated $856K and bringing the position to 3,099 shares worth $1.12M. The position accounts for 0.31% of the portfolio, ranked #61.

Wealth Management Associates first reported a position in AMGN in Q4 2019 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wealth Management Associates held 3,099 shares of Amgen worth $1.12M as of Q2 2026.
  • Wealth Management Associates bought 2,500 Amgen shares in Q2 2026, an estimated $856K.
  • Amgen made up 0.31% of Wealth Management Associates's portfolio in Q2 2026, its #61 holding.
  • Wealth Management Associates first reported a position in Amgen in Q4 2019 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wealth Management Associates's 13F filing for Q2 2026, filed 21 Jul 2026.